Buscar

Estamos realizando la búsqueda. Por favor, espere...

Urine Phenylacetylglutamine Determination in Patients with Hyperphenylalaninemia

Abstract: Phenylketonuria (PKU), an autosomal-recessive inborn error of phenylalanine (Phe) metabolism is the most prevalent disorder of amino acid metabolism. Currently, clinical follow-up relies on frequent monitoring of Phe levels in blood. We hypothesize that the urine level of phenylacetylglutamine (PAG), a phenyl-group marker, could be used as a non-invasive biomarker. In this cross-sectional study, a validated liquid chromatography coupled to tandem mass spectrometry (LC-MS) method was used for urinary PAG quantification in 35 participants with hyperphenylalaninemia (HPA) and 33 age- and sex-matched healthy controls. We have found that (a) PKU patients present higher urine PAG levels than healthy control subjects, and that (b) there is a significant correlation between urine PAG and circulating Phe levels in patients with HPA. In addition, we show a significant strong correlation between Phe levels from venous blood samples and from capillary finger-prick dried blood spot (DBS) samples collected at the same time in patients with HPA. Further research in order to assess the potential role of urine PAG as a non-invasive biomarker in PKU is warranted.

 Fuente: Journal of clinical medicine 2021, 10, 3674

 Editorial: MDPI

 Fecha de publicación: 19/08/2021

 Nº de páginas: 11

 Tipo de publicación: Artículo de Revista

 DOI: doi.org/10.3390/jcm10163674

 ISSN: 2077-0383

 Url de la publicación: https://doi.org/10.3390/jcm10163674

Autoría

ANDRADE, FERNANDO

CANO, AINARA

UNCETA SUAREZ, MARÍA

ARZA, ARANTZA

VINUESA, ANA

CEBERIO, LETICIA

LÓPEZ-OSLÉ, NURIA

FRUTOS, GORKA DE

LÓPEZ-OCEJA, RAQUEL

AZNAL, ELENA

HERAS, JAVIER DE LAS